Vertex Pharmaceuticals

VRTX

Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, near Oxford, England.

Vertex Pharmaceuticals has been a target of short sellers for a while. The current short interest of 1.84% is roughly at the average of the last 12 months (1.71%).